Search Within

Heiko Schoder

  1. "Solid Tumor Oncology Division"
Formats
  1. Meeting Abstract (68)
  2. Journal Article (61)
  3. Book Section (1)
  4. Editorial (1)
  5. Review (1)
Groups
  1. Department of Medicine (132)
  2. Molecular Imaging and Therapy Service (132)
  3. Radiology, Department of (132)
  4. Solid Tumor Oncology Division (132)
  5. Survivorship Research (61)
  6. Epidemiology and Biostatistics (60)

More Groups

People
  1. John Humm (38)
  2. Nancy Lee (32)
  3. Steven Larson (32)
  4. Eric Sherman (30)
  5. Howard Scher (25)
  6. Michael Morris (25)

More People

Years
  1. 2025 (3)
  2. 2024 (17)
  3. 2023 (11)
  4. 2022 (9)
  5. 2021 (11)
  6. 2020 (5)

More Years

Publications
  1. Journal of Clinical Oncology (39)
  2. International Journal of Radiation Oncology, Biology, Physics (17)
  3. Journal of Nuclear Medicine (15)
  4. Blood (8)
  5. Clinical Cancer Research (4)
  6. European Journal of Nuclear Medicine and Molecular Imaging (4)

More Publications

Publishers
  1. American Society of Clinical Oncology (39)
  2. Elsevier Inc. (22)
  3. Society of Nuclear Medicine (15)
  4. Springer (13)
  5. American Society of Hematology (8)
  6. American Association for Cancer Research (7)

More Publishers

Results (132)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Brentuximab vedotin and AVD followed by involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma
    Journal Article

    Kumar, A.; Casulo, C.; Yahalom, J.; Schòˆder, H.; Barr, P. M.; Caron, P.; Chiu, A.; Constine, L. S.; Drullinsky, P.; Friedberg, J. W.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • A phase 2 trial of everolimus and pasireotide long-acting release in patients with metastatic uveal melanoma
    Journal Article

    Shoushtari, A. N.; Ong, L. T.; Schoder, H.; Singh-Kandah, S.; Abbate, K. T.; Postow, M. A.; Callahan, M. K.; Wolchok, J.; Chapman, P. B.; Panageas, K. S.; more...
    Melanoma Research (2016)

    Fulltext@MSK | Save
  • Phase II trial of bevacizumab + cetuximab + cisplatin with concurrent intensity-modulated radiation therapy for patients with stage III/IVB head and neck squamous cell carcinoma
    Journal Article

    Fury, M. G.; Xiao, H.; Sherman, E. J.; Baxi, S.; Smith-Marrone, S.; Schupak, K.; Gewanter, R.; Gelblum, D.; Haque, S.; Schoder, H.; more...
    Head & Neck (2016)

    Fulltext@MSK | Save
  • Novel approaches to thyroid cancer treatment and response assessment
    Journal Article

    Grewal, R. K.; Ho, A.; Schòˆder, H.
    Seminars in Nuclear Medicine (2016)

    Fulltext@MSK | Save
  • Can metabolic tumor volume further risk stratify patients eligible for treatment deintensification in the newly proposed HPV-associated oropharyngeal cancer staging system?
    Meeting Abstract

    Romesser, P. B.; Ong, L.; Wong, R. J.; Sherman, E. J.; Riaz, N.; McBride, S. M.; Katabi, N.; Schoder, H.; Lee, N.
    International Journal of Radiation Oncology, Biology, Physics (2015)

    Fulltext@MSK | Save
  • Prognostic significance of PET assessment of metabolic response to therapy in oesophageal squamous cell carcinoma
    Journal Article

    Chhabra, A.; Ong, L. T.; Kuk, D.; Ku, G.; Ilson, D.; Janjigian, Y. Y.; Wu, A.; Schoder, H.; Goodman, K. A.
    British Journal of Cancer (2015)

    Fulltext@MSK | Save
  • A phase I trial of sorafenib with whole brain radiotherapy (WBRT) in breast cancer patients with brain metastases and a correlative study of FLT-PET brain imaging to evaluate treatment response after WBRT sorafenib
    Meeting Abstract

    Morikawa, A.; Jhaveri, K. L.; Patil, S.; Chen, M.; Mcdonnell, E.; Neville, D. A.; Mak, F. M.; Gansukh, B.; Humm, J. L.; Holodny, A.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Pathologic correlation of 18F-16 beta-fluoro-5 alpha-dihydrotestosterone (FDHT) and FDG PET in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Feldman, J. L.; Fox, J. J.; Martinez, D. F.; Autio, K. A.; Durack, J. C.; Humm, J.; Schoder, H.; Gavane, S. C.; Curtis, K. R.; Balakirsky, S. M.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Safety and early efficacy in an ongoing pilot study of brentuximab vedotin and AVD chemotherapy followed by 30 gray involved-site radiotherapy for newly diagnosed, early stage, unfavorable risk Hodgkin lymphoma
    Meeting Abstract

    Kumar, A.; Yahalom, J.; Schoder, H.; Caron, P.; Drullinsky, P.; Gerecitano, J. F.; Hamilton, A.; Hamlin, P.; Horwitz, S. M.; Jacob, A. G.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Prognostic significance of FDG-PET metrics in esophageal squamous cell carcinoma
    Meeting Abstract

    Chhabra, A. M.; Ong, L. T.; Kuk, D.; Ku, G.; Ilson, D.; Janjigian, Y. Y.; Wu, A.; Schoder, H.; Goodman, K. A.
    International Journal of Radiation Oncology, Biology, Physics (2014)

    Fulltext@MSK | Save